Sunday, December 14, 2025 | 02:01 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Concerns over Oxford Covid-19 vaccine likely to impact export demand

Vaccine exports picked up last month; Serum shipped 11.9 mn to WHO-Gavi pool

Photo: Bloomberg
premium

Several countries have fully or partially suspended the use of AstraZeneca-Oxford vaccines for fear of adverse events following vaccination like blood clots

Sohini Das Mumbai
Vaccine exports have been on the fast lane from India, but the concerns over adverse effects of Astra­Zeneca-Oxford jab may impact the momentum.
 
Till the first week of March, India has exported 48.1 million doses of vaccines to various countries – commercially, as grant, and for the Covax facility. Till the mid-February, the country had exported 16 million doses of Covid-19 vaccines, of which about 37 per cent were grants to neighbours for strategic reasons.
 
The data shared by the ministry of external affairs in the Lok Sabha shows around 15 per cent of the exports till March